Evidence map›Paper›PMID 35895824›Full record

ArticleScience advances2022

Through-skull brain imaging in vivo at visible wavelengths via dimensionality reduction adaptive-optical microscopy.

Yonghyeon Jo, Ye-Ryoung Lee, Jin Hee Hong, Dong-Young Kim, Junhwan Kwon, Myunghwan Choi, Moonseok Kim, Wonshik Choi

Abstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yonghyeon JoCenter for Molecular Spectroscopy and Dynamics, Institute for Basic Science, Seoul 02841, Republic of Korea.ORCID 0000-0002-4487-1735
Ye-Ryoung LeeCenter for Molecular Spectroscopy and Dynamics, Institute for Basic Science, Seoul 02841, Republic of Korea.ORCID 0000-0003-4292-8424
Jin Hee HongCenter for Molecular Spectroscopy and Dynamics, Institute for Basic Science, Seoul 02841, Republic of Korea.ORCID 0000-0001-6356-8857
Dong-Young KimCenter for Molecular Spectroscopy and Dynamics, Institute for Basic Science, Seoul 02841, Republic of Korea.ORCID 0000-0002-1026-1162
Junhwan KwonSchool of Biological Sciences, Seoul National University, Seoul, Republic of Korea.
Myunghwan ChoiSchool of Biological Sciences, Seoul National University, Seoul, Republic of Korea.ORCID 0000-0002-4235-7003
Moonseok KimDepartment of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.ORCID 0000-0003-3100-8980
Wonshik ChoiCenter for Molecular Spectroscopy and Dynamics, Institute for Basic Science, Seoul 02841, Republic of Korea.ORCID 0000-0002-9445-7081

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Compensation of sample-induced optical aberrations is crucial for visualizing microscopic structures deep within biological tissues. However, strong multiple scattering poses a fundamental limitation for identifying and correcting the tissue-induced aberrations. Here, we introduce a label-free deep-tissue imaging technique termed dimensionality reduction adaptive-optical microscopy (DReAM) to selectively attenuate multiple scattering. We established a theoretical framework in which dimensionality reduction of a time-gated reflection matrix can attenuate uncorrelated multiple scattering while retaining a single-scattering signal with a strong wave correlation, irrespective of sample-induced aberrations. We performed mouse brain imaging in vivo through the intact skull with the probe beam at visible wavelengths. Despite the strong scattering and aberrations, DReAM offered a 17-fold enhancement of single scattering-to-multiple scattering ratio and provided high-contrast images of neural fibers in the brain cortex with the diffraction-limited spatial resolution of 412 nanometers and a 33-fold enhanced Strehl ratio.

Identifiers

PMID35895824
PMCPMC9328682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.